Original language | English (US) |
---|---|
Pages (from-to) | E273-E274 |
Journal | Critical care medicine |
Volume | 46 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2018 |
Bibliographical note
Funding Information:Dr. Scheer received funding from travel reimbursement and conference expenses from Astellas, and lecture fees from Dräger Medical and Radiometer. Dr. Kuhn’s institution received funding from Federal Ministry of Education and research (BMBF) Germany and Dräger medical Germany, and he received funding from Lilly Medical. Dr. Rehberg’s institution received funding from Fresenius Kabi Germany, Orion Pharma, and Amomed Pharma.